Linked inTwitter

Halcyon's 52:52:52 campaign on this site and on Twitter will start in 2021. It will help you address 52 issues with 52 responses over 52 weeks.

Part consultancy, part thinktank, part social enterprise, Halcyon helps you prepare for and respond to personal, organisational and societal change.

A Mundane Comedy is Halcyon's new book. Extracts will appear on this site and across social media from the beginning of 2021. Please get in touch with any questions about the book or related Halcyon services.

Halcyon monitors change for more than 150 key elements of life.

Genes

What's Changing? - Identity
Identity
Halcyon Identifies 22 November 2020

 

Please see below selected recent identity-related change.

 

See also:

 

November 2020

On CRISPR

Genetics

 

40%: The percentage of patients reported to have responded to one of the most advanced CRISPR cancer therapy studies to be tested in China. China is far ahead of the US in CRISPR cancer studies due to its less stringent approval requirements, but the US and Europe are set to see their first human trials of the gene-editing technique this year. With potentially transformative implications across medicine, agriculture, and even chemical products, CB Insights' 5,200-word CRISPR deep dive unpacks the science behind the technology, its applications, controversies it’s stirred up, and where CRISPR may take us next.